Advocacy in dementia

G. Stokin
{"title":"Advocacy in dementia","authors":"G. Stokin","doi":"10.1093/med/9780198796039.003.0025","DOIUrl":null,"url":null,"abstract":"Advocacy in dementia can be defined best as the act or process by an individual or a group influencing or otherwise supporting within social, health, economic, and political systems and organizations better dementia care at large. Dementia advocacy encompasses many activities including among others public speaking and media campaigns, sharing knowledge and experiences, providing resources including funding, establishing groups and organizations, developing and presenting guidelines, criteria, programmes, strategies, and policies and consulting regional, national, and international decision-makers to promote, support, and otherwise further dementia care. Recently, the World Health Organization recognized dementia as a global epidemic with the majority of people afflicted by dementia originating from low- to middle-income countries where access to dementia care is limited or absent. Indeed, there is an urgent need to develop cost-effective strategies to deliver sufficient and efficient dementia care as well as to optimize needed resources including finances. This need can only be fulfilled with diligent advocacy, which initially played a crucial role in defining the modern notion of dementia and more recently propelled dementia to the centre stage of healthcare priorities across the globe.","PeriodicalId":383831,"journal":{"name":"Advocacy in Neurology","volume":"22 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advocacy in Neurology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/med/9780198796039.003.0025","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Advocacy in dementia can be defined best as the act or process by an individual or a group influencing or otherwise supporting within social, health, economic, and political systems and organizations better dementia care at large. Dementia advocacy encompasses many activities including among others public speaking and media campaigns, sharing knowledge and experiences, providing resources including funding, establishing groups and organizations, developing and presenting guidelines, criteria, programmes, strategies, and policies and consulting regional, national, and international decision-makers to promote, support, and otherwise further dementia care. Recently, the World Health Organization recognized dementia as a global epidemic with the majority of people afflicted by dementia originating from low- to middle-income countries where access to dementia care is limited or absent. Indeed, there is an urgent need to develop cost-effective strategies to deliver sufficient and efficient dementia care as well as to optimize needed resources including finances. This need can only be fulfilled with diligent advocacy, which initially played a crucial role in defining the modern notion of dementia and more recently propelled dementia to the centre stage of healthcare priorities across the globe.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
痴呆症的宣传
对痴呆症的倡导可以最好地定义为个人或团体在社会、卫生、经济和政治系统和组织中影响或以其他方式支持更好的痴呆症护理的行为或过程。痴呆症宣传包括许多活动,其中包括公开演讲和媒体宣传、分享知识和经验、提供资源(包括资助)、建立团体和组织、制定和提出指南、标准、规划、战略和政策,以及咨询区域、国家和国际决策者,以促进、支持和以其他方式进一步开展痴呆症护理。最近,世界卫生组织确认痴呆症是一种全球流行病,大多数痴呆症患者来自低收入和中等收入国家,这些国家获得痴呆症护理的机会有限或根本没有。事实上,迫切需要制定具有成本效益的战略,以提供充分和有效的痴呆症护理,并优化包括资金在内的所需资源。这一需求只能通过勤奋的宣传来满足,这种宣传最初在定义痴呆症的现代概念方面发挥了关键作用,最近又将痴呆症推向了全球卫生保健优先事项的中心舞台。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Results, outlook, and goals of this book Using PR tools for advocacy Advocacy, campaigning, lobbying: Good or bad? Advocacy for epilepsy: From the shadows to centre stage: Stand up for epilepsy Physician autonomy and the pharmaceutical industry
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1